APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pegfilgrastim

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pegfilgrastim Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchPegfilgrastim Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Pegfilgrastim Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Pegfilgrastim Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pegfilgrastim Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pegfilgrastim Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pegfilgrastim market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pegfilgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pegfilgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pegfilgrastim is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pegfilgrastim market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pegfilgrastim market include Mylan, Roche and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pegfilgrastim market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pegfilgrastim and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pegfilgrastim sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pegfilgrastim market size, projected growth trends, production technologies, key applications, and end-use industries.

Pegfilgrastim Segment by Company

Mylan

Roche

Amgen

Pegfilgrastim Segment by Type

Originator Biologic Drug

Biosimilar Versions

Pegfilgrastim Segment by Application

Hospital

Drug store

Pegfilgrastim Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pegfilgrastim status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pegfilgrastim market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pegfilgrastim significant trends, drivers, influence factors in global and regions.

6. To analyze Pegfilgrastim competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pegfilgrastim market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pegfilgrastim and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pegfilgrastim.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pegfilgrastim market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pegfilgrastim industry.

Chapter 3: Detailed analysis of Pegfilgrastim manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pegfilgrastim in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pegfilgrastim in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pegfilgrastim Industry Trends Table 2. Pegfilgrastim Industry Drivers Table 3. Pegfilgrastim Industry Opportunities and Challenges Table 4. Pegfilgrastim Industry Restraints Table 5. Global Pegfilgrastim Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pegfilgrastim Revenue Share by Company (2021-2026) Table 7. Global Pegfilgrastim Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pegfilgrastim Sales Volume Share by Company (2021-2026) Table 9. Global Pegfilgrastim Average Price (US$/unit) of Company (2021-2026) Table 10. Global Pegfilgrastim Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pegfilgrastim Key Company Manufacturing Base & Headquarters Table 12. Global Pegfilgrastim Company, Product Type & Application Table 13. Global Pegfilgrastim Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pegfilgrastim by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Originator Biologic Drug Table 18. Significant Companies of Biosimilar Versions Table 19. Global Pegfilgrastim Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Pegfilgrastim Sales Volume by Type (2021-2026) & (k units) Table 21. Global Pegfilgrastim Sales Volume by Type (2027-2032) & (k units) Table 22. Global Pegfilgrastim Sales Volume Share by Type (2021-2026) Table 23. Global Pegfilgrastim Sales Volume Share by Type (2027-2032) Table 24. Global Pegfilgrastim Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pegfilgrastim Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pegfilgrastim Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pegfilgrastim Sales Value Share by Type (2021-2026) Table 28. Global Pegfilgrastim Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Drug store Table 31. Global Pegfilgrastim Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Pegfilgrastim Sales Volume by Application (2021-2026) & (k units) Table 33. Global Pegfilgrastim Sales Volume by Application (2027-2032) & (k units) Table 34. Global Pegfilgrastim Sales Volume Share by Application (2021-2026) Table 35. Global Pegfilgrastim Sales Volume Share by Application (2027-2032) Table 36. Global Pegfilgrastim Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pegfilgrastim Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Pegfilgrastim Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Pegfilgrastim Sales Value Share by Application (2021-2026) Table 40. Global Pegfilgrastim Sales Value Share by Application (2027-2032) Table 41. Global Pegfilgrastim Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Pegfilgrastim Sales by Region (2021-2026) & (k units) Table 43. Global Pegfilgrastim Sales Market Share by Region (2021-2026) Table 44. Global Pegfilgrastim Sales by Region (2027-2032) & (k units) Table 45. Global Pegfilgrastim Sales Market Share by Region (2027-2032) Table 46. Global Pegfilgrastim Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pegfilgrastim Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Pegfilgrastim Sales Value Share by Region (2021-2026) Table 49. Global Pegfilgrastim Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Pegfilgrastim Sales Value Share by Region (2027-2032) Table 51. Global Pegfilgrastim Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Pegfilgrastim Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Pegfilgrastim Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Pegfilgrastim Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Pegfilgrastim Sales by Country (2021-2026) & (k units) Table 56. Global Pegfilgrastim Sales Market Share by Country (2021-2026) Table 57. Global Pegfilgrastim Sales by Country (2027-2032) & (k units) Table 58. Global Pegfilgrastim Sales Market Share by Country (2027-2032) Table 59. Global Pegfilgrastim Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Pegfilgrastim Sales Value Market Share by Country (2021-2026) Table 61. Global Pegfilgrastim Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Pegfilgrastim Sales Value Market Share by Country (2027-2032) Table 63. Mylan Company Information Table 64. Mylan Business Overview Table 65. Mylan Pegfilgrastim Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Mylan Pegfilgrastim Product Portfolio Table 67. Mylan Recent Development Table 68. Roche Company Information Table 69. Roche Business Overview Table 70. Roche Pegfilgrastim Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Roche Pegfilgrastim Product Portfolio Table 72. Roche Recent Development Table 73. Amgen Company Information Table 74. Amgen Business Overview Table 75. Amgen Pegfilgrastim Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Amgen Pegfilgrastim Product Portfolio Table 77. Amgen Recent Development Table 78. Key Raw Materials Table 79. Raw Materials Key Suppliers Table 80. Pegfilgrastim Distributors List Table 81. Pegfilgrastim Customers List Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Pegfilgrastim Product Image Figure 2. Global Pegfilgrastim Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pegfilgrastim Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pegfilgrastim Sales (2021-2032) & (k units) Figure 5. Global Pegfilgrastim Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Pegfilgrastim Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Originator Biologic Drug Image Figure 10. Biosimilar Versions Image Figure 11. Global Pegfilgrastim Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Pegfilgrastim Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pegfilgrastim Sales Volume Share by Type (2021-2032) Figure 14. Global Pegfilgrastim Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pegfilgrastim Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pegfilgrastim Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drug store Image Figure 19. Global Pegfilgrastim Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Pegfilgrastim Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Pegfilgrastim Sales Volume Share by Application (2021-2032) Figure 22. Global Pegfilgrastim Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Pegfilgrastim Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Pegfilgrastim Sales Value Share by Application (2021-2032) Figure 25. Global Pegfilgrastim Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Pegfilgrastim Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Pegfilgrastim Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Pegfilgrastim Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Pegfilgrastim Sales Value (2021-2032) & (US$ Million) Figure 30. North America Pegfilgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Pegfilgrastim Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Pegfilgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Pegfilgrastim Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Pegfilgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Pegfilgrastim Sales Value (2021-2032) & (US$ Million) Figure 36. South America Pegfilgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Pegfilgrastim Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Pegfilgrastim Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Pegfilgrastim Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Pegfilgrastim Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Pegfilgrastim Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Pegfilgrastim Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Pegfilgrastim Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Originator Biologic Drug
  • Biosimilar Versions
Applications
  • Hospital
  • Drug store
Companies covered
  • Mylan
  • Roche
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pegfilgrastim Sales Value (2021-2032)
  4. 1.2.2 Global Pegfilgrastim Sales Volume (2021-2032)
  5. 1.2.3 Global Pegfilgrastim Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pegfilgrastim Market Dynamics
  1. 2.1 Pegfilgrastim Industry Trends
  2. 2.2 Pegfilgrastim Industry Drivers
  3. 2.3 Pegfilgrastim Industry Opportunities and Challenges
  4. 2.4 Pegfilgrastim Industry Restraints
3 Pegfilgrastim Market by Company
  1. 3.1 Global Pegfilgrastim Company Revenue Ranking in 2025
  2. 3.2 Global Pegfilgrastim Revenue by Company (2021-2026)
  3. 3.3 Global Pegfilgrastim Sales Volume by Company (2021-2026)
  4. 3.4 Global Pegfilgrastim Average Price by Company (2021-2026)
  5. 3.5 Global Pegfilgrastim Company Ranking (2024-2026)
  6. 3.6 Global Pegfilgrastim Company Manufacturing Base and Headquarters
  7. 3.7 Global Pegfilgrastim Company Product Type and Application
  8. 3.8 Global Pegfilgrastim Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pegfilgrastim Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pegfilgrastim Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pegfilgrastim Market by Type
  1. 4.1 Pegfilgrastim Type Introduction
  2. 4.1.1 Originator Biologic Drug
  3. 4.1.2 Biosimilar Versions
  4. 4.2 Global Pegfilgrastim Sales Volume by Type
  5. 4.2.1 Global Pegfilgrastim Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pegfilgrastim Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pegfilgrastim Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pegfilgrastim Sales Value by Type
  9. 4.3.1 Global Pegfilgrastim Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pegfilgrastim Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pegfilgrastim Sales Value Share by Type (2021-2032)
5 Pegfilgrastim Market by Application
  1. 5.1 Pegfilgrastim Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Pegfilgrastim Sales Volume by Application
  5. 5.2.1 Global Pegfilgrastim Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pegfilgrastim Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Pegfilgrastim Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Pegfilgrastim Sales Value by Application
  9. 5.3.1 Global Pegfilgrastim Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pegfilgrastim Sales Value by Application (2021-2032)
  11. 5.3.3 Global Pegfilgrastim Sales Value Share by Application (2021-2032)
6 Pegfilgrastim Regional Sales and Value Analysis
  1. 6.1 Global Pegfilgrastim Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pegfilgrastim Sales by Region (2021-2032)
  3. 6.2.1 Global Pegfilgrastim Sales by Region: 2021-2026
  4. 6.2.2 Global Pegfilgrastim Sales by Region (2027-2032)
  5. 6.3 Global Pegfilgrastim Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pegfilgrastim Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pegfilgrastim Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pegfilgrastim Sales Value by Region (2027-2032)
  9. 6.5 Global Pegfilgrastim Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pegfilgrastim Sales Value (2021-2032)
  12. 6.6.2 North America Pegfilgrastim Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pegfilgrastim Sales Value (2021-2032)
  15. 6.7.2 Europe Pegfilgrastim Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pegfilgrastim Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pegfilgrastim Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pegfilgrastim Sales Value (2021-2032)
  21. 6.9.2 South America Pegfilgrastim Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pegfilgrastim Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pegfilgrastim Sales Value Share by Country, 2025 VS 2032
7 Pegfilgrastim Country-level Sales and Value Analysis
  1. 7.1 Global Pegfilgrastim Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pegfilgrastim Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pegfilgrastim Sales by Country (2021-2032)
  4. 7.3.1 Global Pegfilgrastim Sales by Country (2021-2026)
  5. 7.3.2 Global Pegfilgrastim Sales by Country (2027-2032)
  6. 7.4 Global Pegfilgrastim Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pegfilgrastim Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pegfilgrastim Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pegfilgrastim Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pegfilgrastim Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pegfilgrastim Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pegfilgrastim Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pegfilgrastim Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pegfilgrastim Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pegfilgrastim Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pegfilgrastim Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pegfilgrastim Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pegfilgrastim Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pegfilgrastim Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pegfilgrastim Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pegfilgrastim Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pegfilgrastim Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pegfilgrastim Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pegfilgrastim Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pegfilgrastim Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pegfilgrastim Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pegfilgrastim Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pegfilgrastim Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pegfilgrastim Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pegfilgrastim Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pegfilgrastim Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pegfilgrastim Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pegfilgrastim Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pegfilgrastim Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pegfilgrastim Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pegfilgrastim Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pegfilgrastim Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pegfilgrastim Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mylan
  2. 8.1.1 Mylan Company Information
  3. 8.1.2 Mylan Business Overview
  4. 8.1.3 Mylan Pegfilgrastim Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mylan Pegfilgrastim Product Portfolio
  6. 8.1.5 Mylan Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Pegfilgrastim Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Roche Pegfilgrastim Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Amgen
  14. 8.3.1 Amgen Company Information
  15. 8.3.2 Amgen Business Overview
  16. 8.3.3 Amgen Pegfilgrastim Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amgen Pegfilgrastim Product Portfolio
  18. 8.3.5 Amgen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pegfilgrastim Value Chain Analysis
  2. 9.1.1 Pegfilgrastim Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pegfilgrastim Sales Mode & Process
  6. 9.2 Pegfilgrastim Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pegfilgrastim Distributors
  9. 9.2.3 Pegfilgrastim Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst